The tyrosine kinase receptor, ALK, was first discovered in chromosomal translocations associated with anaplastic large cell lymphoma, and it is associated with the occurrence and progression of a variety of cancers, such as non-small cell lung cancer, neuroblastoma, renal cell carcinoma, as well as others [66]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.